Healthcare Infection Control Practices Advisory Committee (HICPAC), 66383 [2014-26511]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 216 / Friday, November 7, 2014 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2014–26510 Filed 11–6–14; 8:45 am]
[FR Doc. 2014–26511 Filed 11–6–14; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Medicare & Medicaid
Services
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
mstockstill on DSK4VPTVN1PROD with NOTICES
9:00 a.m.–5:00 p.m., December 4, 2014
9:00 a.m.–12:00 p.m., December 5, 2014
Place: Emory Conference Center, The
Silverbell Pavilion, 1615 Clifton Rd, Atlanta,
Georgia, 30329.
Status: Open to the public, limited only by
the space available. Please register for the
meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with
providing advice and guidance to the
Director, Division of Healthcare Quality
Promotion, the Director, National Center for
Emerging and Zoonotic Infectious Diseases
(NCEZID), the Director, CDC, the Secretary,
Health and Human Services regarding (1) the
practice of healthcare infection prevention
and control; (2) strategies for surveillance,
prevention, and control of infections,
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of CDC guidelines and
other policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters for Discussion: The agenda will
include updates on CDC’s activities for
prevention of healthcare associated
infections (HAIs), updates on antimicrobial
resistance, an update on Draft Guidelines,
and updates on healthcare preparedness and
emerging infections.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Erin
Stone, M.S., HICPAC, Division of Healthcare
Quality Promotion, NCEZID, CDC, l600
Clifton Road NE., Mailstop A–07, Atlanta,
Georgia 30333 Telephone (404) 639–4045.
Email: hicpac@cdc.gov
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
19:12 Nov 06, 2014
Emergency Clearance: Public
Information Collection Requirements
Submitted to the Office of Management
and Budget (OMB)
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
any of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
We are, however, requesting an
emergency review of the information
collection referenced below. In
compliance with the requirement of
section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995, we have
submitted to the Office of Management
and Budget (OMB) the following
requirements for emergency review.
This is necessary to ensure compliance
with an initiative of the Administration.
We are requesting an emergency review
under 5 CFR Part 1320(a)(2)(i) because
public harm is reasonably likely to
result if the normal clearance
procedures are followed. We are seeking
emergency approval for modifications to
the information collection request (ICR)
SUMMARY:
Times and Dates
VerDate Sep<11>2014
[Document Identifiers: CMS–10371]
Jkt 235001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
66383
currently approved under Office of
Management and Budget (OMB) control
number 0938–1119 in order to
collection additional information during
the 2015 open enrollment periods from
the 14 operational SBMs (including
Washington, DC) to enhance the
agency’s understanding of the
demographic makeup of the citizens
enrolling in the various health plans as
well as the affordability of those plans.
Existing collections gather information
from the grant awardee to ensure the
CMS is able to conduct their statutory
oversight responsibilities. The revision
to the weekly reporting requirement is
necessary to obtain more accurate and
consistent enrollment data during the
upcoming Open Enrollment Period
which begins November 15, 2014. The
immediate need for this revision is due
to the State-Based Marketplaces (SBM)
maturing business processes and the
requirement for more precise reporting
of comparison data between the first
and second years of ACA
implementation. The changes to the
revised format of the Weekly Report
have been presented to all participating
states. CMS is requesting an emergency
modification to the weekly reporting
template in order to capture certain
demographic data and information on
new versus re-enrolled individuals in
accordance with uniform definitions so
as not to produce misleading results.
Comments must be received by
November 14, 2014.
DATES:
When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: CMS–10371/OMB Control
Number 0938–1119, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following
ADDRESSES:
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 79, Number 216 (Friday, November 7, 2014)]
[Notices]
[Page 66383]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-26511]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a) (2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
committee:
Times and Dates
9:00 a.m.-5:00 p.m., December 4, 2014
9:00 a.m.-12:00 p.m., December 5, 2014
Place: Emory Conference Center, The Silverbell Pavilion, 1615
Clifton Rd, Atlanta, Georgia, 30329.
Status: Open to the public, limited only by the space available.
Please register for the meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion,
the Director, National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), the Director, CDC, the Secretary, Health and
Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related
events in settings where healthcare is provided; and (3) periodic
updating of CDC guidelines and other policy statements regarding
prevention of healthcare-associated infections and healthcare-
related conditions.
Matters for Discussion: The agenda will include updates on CDC's
activities for prevention of healthcare associated infections
(HAIs), updates on antimicrobial resistance, an update on Draft
Guidelines, and updates on healthcare preparedness and emerging
infections.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE., Mailstop A-07, Atlanta, Georgia 30333 Telephone (404) 639-
4045. Email: hicpac@cdc.gov
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 2014-26511 Filed 11-6-14; 8:45 am]
BILLING CODE 4163-18-P
